Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza A Virus, H1N1 Subtype | 10 | 2022 | 42 | 4.490 |
Why?
|
| Lung | 15 | 2023 | 376 | 4.450 |
Why?
|
| Influenza, Human | 9 | 2022 | 85 | 3.880 |
Why?
|
| Orthomyxoviridae Infections | 7 | 2022 | 40 | 3.710 |
Why?
|
| Bacillus anthracis | 14 | 2023 | 151 | 3.190 |
Why?
|
| Influenza A virus | 5 | 2022 | 33 | 2.760 |
Why?
|
| Anthrax | 8 | 2023 | 89 | 2.720 |
Why?
|
| Immunity, Innate | 13 | 2018 | 225 | 2.700 |
Why?
|
| Macrophages, Alveolar | 7 | 2020 | 36 | 2.240 |
Why?
|
| DEAD Box Protein 58 | 7 | 2018 | 18 | 1.720 |
Why?
|
| Antigens, Bacterial | 4 | 2020 | 161 | 1.720 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2015 | 26 | 1.660 |
Why?
|
| Spores, Bacterial | 7 | 2023 | 49 | 1.650 |
Why?
|
| Bacterial Toxins | 4 | 2020 | 267 | 1.540 |
Why?
|
| Dendritic Cells | 4 | 2018 | 143 | 1.490 |
Why?
|
| Epithelial Cells | 7 | 2023 | 247 | 1.330 |
Why?
|
| Smoke | 3 | 2021 | 34 | 1.320 |
Why?
|
| Interferons | 3 | 2020 | 69 | 1.240 |
Why?
|
| Smoking | 4 | 2017 | 473 | 1.150 |
Why?
|
| Alveolar Epithelial Cells | 3 | 2020 | 15 | 1.150 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 451 | 0.980 |
Why?
|
| Macrophages | 4 | 2018 | 296 | 0.970 |
Why?
|
| Cytokines | 8 | 2011 | 446 | 0.890 |
Why?
|
| Toll-Like Receptor 3 | 4 | 2018 | 17 | 0.870 |
Why?
|
| Cigarette Smoking | 2 | 2022 | 81 | 0.840 |
Why?
|
| Adenoviruses, Human | 3 | 2010 | 22 | 0.830 |
Why?
|
| Antiviral Agents | 3 | 2020 | 112 | 0.810 |
Why?
|
| Humans | 38 | 2023 | 28155 | 0.800 |
Why?
|
| Phagocytosis | 3 | 2020 | 80 | 0.800 |
Why?
|
| Chemokines | 4 | 2018 | 74 | 0.780 |
Why?
|
| Lung Injury | 1 | 2022 | 32 | 0.750 |
Why?
|
| Communicable Diseases | 1 | 2022 | 21 | 0.740 |
Why?
|
| Pneumonia | 1 | 2022 | 89 | 0.720 |
Why?
|
| Tobacco Products | 2 | 2021 | 198 | 0.700 |
Why?
|
| Interferon-gamma | 1 | 2021 | 107 | 0.690 |
Why?
|
| Bronchi | 2 | 2021 | 38 | 0.690 |
Why?
|
| Pinocytosis | 1 | 2020 | 17 | 0.680 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2020 | 6 | 0.670 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 208 | 0.670 |
Why?
|
| Leukocytes | 1 | 2020 | 72 | 0.660 |
Why?
|
| Animals | 17 | 2022 | 10415 | 0.660 |
Why?
|
| Interferon Type I | 1 | 2020 | 55 | 0.660 |
Why?
|
| Respiratory Tract Infections | 3 | 2018 | 39 | 0.640 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 283 | 0.630 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 62 | 0.630 |
Why?
|
| Tobacco | 2 | 2022 | 87 | 0.620 |
Why?
|
| Interferon-beta | 5 | 2022 | 40 | 0.620 |
Why?
|
| Immunotherapy | 1 | 2020 | 158 | 0.600 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 248 | 0.590 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 162 | 0.550 |
Why?
|
| Mice | 11 | 2022 | 4655 | 0.540 |
Why?
|
| Rest | 1 | 2018 | 94 | 0.540 |
Why?
|
| Interleukin-8 | 3 | 2018 | 45 | 0.510 |
Why?
|
| Lymph Nodes | 1 | 2016 | 103 | 0.490 |
Why?
|
| Movement | 1 | 2016 | 98 | 0.490 |
Why?
|
| DNA Methylation | 1 | 2016 | 153 | 0.470 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 147 | 0.470 |
Why?
|
| Cells, Cultured | 6 | 2021 | 985 | 0.460 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 91 | 0.450 |
Why?
|
| Antioxidants | 2 | 2014 | 225 | 0.450 |
Why?
|
| Mannose-Binding Lectin | 1 | 2014 | 4 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 6 | 2022 | 1573 | 0.430 |
Why?
|
| Acetylcysteine | 1 | 2014 | 24 | 0.430 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2012 | 11 | 0.430 |
Why?
|
| Receptors, Immunologic | 4 | 2016 | 72 | 0.420 |
Why?
|
| Peptidoglycan | 4 | 2018 | 47 | 0.390 |
Why?
|
| Cell Line | 5 | 2020 | 694 | 0.390 |
Why?
|
| Receptor, Notch3 | 2 | 2021 | 15 | 0.370 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 258 | 0.340 |
Why?
|
| RNA, Messenger | 6 | 2016 | 658 | 0.330 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 9 | 0.330 |
Why?
|
| Organ Culture Techniques | 3 | 2016 | 56 | 0.310 |
Why?
|
| Pneumonia, Viral | 1 | 2010 | 53 | 0.310 |
Why?
|
| Cell Differentiation | 2 | 2021 | 407 | 0.300 |
Why?
|
| NF-kappa B | 1 | 2009 | 191 | 0.300 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 134 | 0.270 |
Why?
|
| Receptors, Peptide | 2 | 2020 | 20 | 0.270 |
Why?
|
| Membrane Glycoproteins | 2 | 2018 | 145 | 0.260 |
Why?
|
| Time Factors | 3 | 2021 | 1593 | 0.260 |
Why?
|
| Virus Internalization | 1 | 2006 | 12 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 87 | 0.250 |
Why?
|
| Enzyme Inhibitors | 3 | 2016 | 250 | 0.240 |
Why?
|
| Calcium | 1 | 2006 | 235 | 0.240 |
Why?
|
| Neutrophils | 4 | 2018 | 181 | 0.230 |
Why?
|
| Monocytes | 3 | 2018 | 135 | 0.230 |
Why?
|
| Up-Regulation | 2 | 2018 | 245 | 0.210 |
Why?
|
| Female | 7 | 2021 | 15183 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2021 | 1433 | 0.200 |
Why?
|
| Dogs | 4 | 2018 | 509 | 0.200 |
Why?
|
| Male | 7 | 2021 | 13505 | 0.200 |
Why?
|
| Interleukin-6 | 2 | 2014 | 194 | 0.190 |
Why?
|
| Sepsis | 2 | 2013 | 84 | 0.190 |
Why?
|
| Goblet Cells | 1 | 2021 | 15 | 0.180 |
Why?
|
| Gene Expression | 2 | 2017 | 416 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 55 | 0.180 |
Why?
|
| Madin Darby Canine Kidney Cells | 2 | 2018 | 7 | 0.180 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 30 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 345 | 0.170 |
Why?
|
| Aged | 3 | 2021 | 5416 | 0.170 |
Why?
|
| Virulence | 2 | 2012 | 151 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2021 | 118 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 608 | 0.170 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 21 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2020 | 8 | 0.170 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 31 | 0.170 |
Why?
|
| Necrosis | 1 | 2020 | 84 | 0.170 |
Why?
|
| Middle Aged | 4 | 2021 | 7164 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 114 | 0.160 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 51 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 327 | 0.160 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 117 | 0.160 |
Why?
|
| Inflammation | 2 | 2022 | 633 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 165 | 0.160 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2018 | 6 | 0.150 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2018 | 7 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 633 | 0.150 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2018 | 19 | 0.150 |
Why?
|
| Immunoassay | 1 | 2018 | 36 | 0.150 |
Why?
|
| Blood | 2 | 2016 | 34 | 0.150 |
Why?
|
| Adult | 3 | 2021 | 7764 | 0.150 |
Why?
|
| Platelet Factor 4 | 1 | 2018 | 5 | 0.150 |
Why?
|
| Chemokine CCL20 | 1 | 2018 | 7 | 0.150 |
Why?
|
| Chemokine CXCL5 | 1 | 2018 | 7 | 0.150 |
Why?
|
| Viral Proteins | 2 | 2010 | 63 | 0.150 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 30 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2017 | 15 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 45 | 0.140 |
Why?
|
| Virus Replication | 1 | 2018 | 64 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2018 | 847 | 0.140 |
Why?
|
| Mortality | 1 | 2017 | 46 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 463 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 57 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 95 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2011 | 513 | 0.140 |
Why?
|
| B7-2 Antigen | 1 | 2016 | 8 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2016 | 12 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2016 | 34 | 0.130 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 15 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2017 | 63 | 0.130 |
Why?
|
| DNA Modification Methylases | 1 | 2016 | 13 | 0.130 |
Why?
|
| Apoptosis | 1 | 2020 | 774 | 0.130 |
Why?
|
| Biomarkers | 1 | 2020 | 763 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 44 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 6 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 140 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2016 | 122 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 32 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 509 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1462 | 0.120 |
Why?
|
| Interleukins | 1 | 2016 | 112 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2016 | 134 | 0.120 |
Why?
|
| Skin | 1 | 2016 | 148 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 133 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 25 | 0.110 |
Why?
|
| Chemokine CXCL10 | 1 | 2014 | 22 | 0.110 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2014 | 5 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2014 | 50 | 0.110 |
Why?
|
| Lectins | 1 | 2014 | 13 | 0.110 |
Why?
|
| Pulmonary Alveoli | 2 | 2018 | 33 | 0.100 |
Why?
|
| Young Adult | 1 | 2020 | 2737 | 0.100 |
Why?
|
| Adolescent | 1 | 2020 | 3126 | 0.100 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 19 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 62 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2012 | 56 | 0.100 |
Why?
|
| Actins | 1 | 2012 | 96 | 0.100 |
Why?
|
| RNA, Viral | 2 | 2018 | 68 | 0.100 |
Why?
|
| Receptors, IgG | 1 | 2012 | 47 | 0.100 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 103 | 0.090 |
Why?
|
| Orthomyxoviridae | 1 | 2011 | 4 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 19 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 67 | 0.090 |
Why?
|
| Pandemics | 1 | 2012 | 185 | 0.090 |
Why?
|
| Oils, Volatile | 1 | 2010 | 4 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2010 | 64 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2009 | 28 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 26 | 0.080 |
Why?
|
| Lysosomes | 1 | 2010 | 56 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 18 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 163 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 76 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 113 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 192 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2012 | 485 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 148 | 0.070 |
Why?
|
| Anthracenes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Butadienes | 1 | 2007 | 14 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 33 | 0.070 |
Why?
|
| Cushing Syndrome | 1 | 2007 | 4 | 0.070 |
Why?
|
| Imidazoles | 1 | 2007 | 63 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 242 | 0.070 |
Why?
|
| Egtazic Acid | 1 | 2006 | 10 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2006 | 12 | 0.070 |
Why?
|
| Pyridines | 1 | 2007 | 108 | 0.060 |
Why?
|
| Critical Illness | 1 | 2007 | 68 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2006 | 267 | 0.060 |
Why?
|
| Defensins | 1 | 2005 | 1 | 0.060 |
Why?
|
| Adenovirus Infections, Human | 1 | 2005 | 8 | 0.060 |
Why?
|
| Pulmonary Surfactants | 1 | 2005 | 11 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 23 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2005 | 34 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2006 | 288 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 60 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2005 | 116 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 80 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 73 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2005 | 123 | 0.060 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2002 | 6 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 30 | 0.050 |
Why?
|
| Cell Physiological Phenomena | 1 | 2002 | 7 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 27 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2002 | 54 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 86 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 346 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 1327 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2007 | 613 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2002 | 118 | 0.050 |
Why?
|
| Air | 1 | 2021 | 23 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2021 | 24 | 0.050 |
Why?
|
| Base Sequence | 1 | 2002 | 585 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 198 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1052 | 0.040 |
Why?
|
| Smokers | 1 | 2021 | 125 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 214 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 724 | 0.040 |
Why?
|
| Mutation | 1 | 2002 | 849 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 806 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 17 | 0.040 |
Why?
|
| Wnt3A Protein | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 58 | 0.040 |
Why?
|
| Viper Venoms | 1 | 2013 | 5 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2013 | 16 | 0.030 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 33 | 0.030 |
Why?
|
| Immune System | 1 | 2013 | 29 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2013 | 38 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2012 | 187 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 354 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 22 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hemagglutination | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2010 | 23 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2011 | 52 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 100 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 252 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 286 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2008 | 65 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 523 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 82 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 366 | 0.020 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2007 | 3 | 0.020 |
Why?
|
| Aminoglutethimide | 1 | 2007 | 3 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Itraconazole | 1 | 2007 | 9 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 306 | 0.020 |
Why?
|
| Gastroplasty | 1 | 2007 | 5 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2007 | 63 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2007 | 115 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2005 | 9 | 0.020 |
Why?
|
| Ligation | 1 | 2005 | 40 | 0.020 |
Why?
|
| Bortezomib | 1 | 2005 | 22 | 0.020 |
Why?
|
| Pyrazines | 1 | 2005 | 24 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2007 | 176 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2005 | 28 | 0.010 |
Why?
|
| Pericardium | 1 | 2005 | 47 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 123 | 0.010 |
Why?
|
| Myocardium | 1 | 2005 | 192 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 394 | 0.010 |
Why?
|